Retraction: Mendelian randomization based on immune cells in diabetic nephropathy
Saved in:
| Main Author: | Frontiers Editorial Office |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Endocrinology |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1575593/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED: Mendelian randomization based on immune cells in diabetic nephropathy
by: Ye Zhou, et al.
Published: (2024-08-01) -
Retraction: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01) -
Retraction: Corrigendum: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01) -
Retraction: Zhu et al. Resveratrol reverts Streptozotocin-induced diabetic nephropathy. Frontiers in Bioscience (Landmark Edition). 2020; 25: 699–709
by: Frontiers in Bioscience-Landmark Editorial Office
Published: (2025-03-01) -
Causal role of immune cells in IgA nephropathy: a mendelian randomization study
by: Jinlian Shu, et al.
Published: (2024-12-01)